Alpha Teknova, Inc. (TKNO) 8-K Current Report — February 26, 2026
Filed: February 26, 2026
Health Care
In Vitro & In Vivo Diagnostic SubstancesAlpha Teknova, Inc. (TKNO) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
Alpha Teknova, Inc. 8-K Feb 26, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full-year 2025 financial results disclosed via press release (Exhibit 99.1)
- • Reporting period: three months and full year ended December 31, 2025
Get deeper insights on Alpha Teknova, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.